Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer

Clinical trial NCT04726215 · UNKNOWN

Trial details

NCT number: NCT04726215
Sponsor: CellSight Technologies, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2021-04-15
Primary completion: 2024-10-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.